Join

Compare · HLN vs PHH

HLN vs PHH

Side-by-side comparison of Haleon plc (HLN) and Park Ha Biological Technology Co. Ltd. (PHH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HLN and PHH operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
  • HLN carries a market cap of $40.61B.
  • Over the past year, HLN is down 15.8% and PHH is down 97.9% - HLN leads by 82.1 points.
  • HLN has hit the wire 12 times in the past 4 weeks while PHH has been quiet.
  • HLN has more recent analyst coverage (19 ratings vs 0 for PHH).
PerformanceHLN-11.33%PHH-97.94%
2026-01-22+0.00%2026-06-10
MetricHLNPHH
Company
Haleon plc
Park Ha Biological Technology Co. Ltd.
Price
$9.16+0.49%
$0.38-0.29%
Market cap
$40.61B
-
1M return
+2.00%
-23.43%
1Y return
-15.81%
-97.94%
Industry
Package Goods/Cosmetics
Package Goods/Cosmetics
Exchange
NYSE
NASDAQ
IPO
2022
2024
News (4w)
12
0
Recent ratings
19
0
HLN

Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.